Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women

Circulation

Volumn 101, Issue 19, 2000, Pages 2258-2263

  Virdis, Agostino ^b   Ghiadoni, Lorenzo ^c   Pinto, Stefania ^c   Lombardo, Maurizio ^c   Petraglia, Felice ^a   Gennazzani, Andrea ^c   Buralli, Simona ^c   Taddei, Stefano ^c   Salvetti, Antonio ^c  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c NONE

Author keywords

Antioxidants; Endothelium; Estrogen; Nitric oxide

Indexed keywords

ACETYLCHOLINE; ANTIOXIDANT; ARGININE; ASCORBIC ACID; ESTROGEN; INDOMETACIN; N(G) METHYLARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PROSTAGLANDIN SYNTHASE;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ENDOTHELIUM; FEMALE; FOREARM BLOOD FLOW; HORMONE DEFICIENCY; HUMAN; LEIOMYOMA; OVARIECTOMY; OXIDATIVE STRESS; PRIORITY JOURNAL; VASODILATATION;

EID: 0034674026     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.19.2258     Document Type: Article

References (39)

1. Kannel WB, Hjortland MC, McNamara PM. Menopause and the risk of cardiovascular disease: the Framingham Study. Ann Intern Med. 1976; 85:447-456.
2. Colditz GA, Willett WC, Stampfer MJ, et al. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316:1105-1110.
3. Stampfer MJ, Golditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N Engl J Med. 1991;325:756-762.
4. Grodstein F, Stampfer MJ. The epidemiology of coronary artery disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis. 1995;38:199-210.
5. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and noncontraceptive estrogen use in women: results from the Lipid Research Clinics program Follow-up Study. Circulation. 1987;75: 1102-1109.
6. Sack MN, Rader DJ, Cannon RO III. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet. 1994;343:269-270.
7. Lüscher TF, Vanhoutte PM. The Endothelium: Modulator of Cardiovascular Function. Boca Raton, Fla: CRC Press; 1990.
8. Vallance P, Coller J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2:997-1000.
9. Katusic ZS, Shepherd JT. Endothelium-derived vasoactive factors, II: endothelium-dependent contraction. Hypertension. 1991;23(suppl III): III-86-III-92.
10. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Nature. 1986;320:454-456.
11. Celermajer DS, Sorensen KE, Spielgelhalter DJ, et al. Aging is associated with endothelial dysfunction in healthy men years before the age related decline in women. J Am Coll Cardiol. 1994;24:471-476.
12. Taddei S, Virdis A, Ghiadoni L, et al. Menopause is associated with endothelial dysfunction in women. Hypertension. 1996;28:576-582.
13. Herrington DM, Braden GA, Williams JK, et al. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am J Cardiol. 1994;73:951-952.
14. Gilligan DM, Badar DM, Panza JA, et al. Acute vascular effects of estrogen in postmenopausal women. Circulation. 1994;90:786-791.
15. Lieberman EH, Gerhard MD, Uehata A, et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med. 1994;121:936-941.
16. Pinto S, Virdis A, Ghiadoni L, et al. Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women. Hypertension. 1997;29:576-582.
17. Whitney RJ. The measurement of volume changes in human limbs. J Physiol (Lond). 1953;121:1-27.
18. Schultz KD, Schultz K, Schultz G. Sodium nitroprusside and other smooth muscle relaxants increase cyclic GMP levels in rat ductus deferens. Nature. 1977;265:750-751.
19. Calver A, Collier J, Vallance P. Dilator actions of arginine in human peripheral vasculature. Clin Sci. 1991;81:695-700.
20. Taddei S, Virdis A, Mattei P, et al. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 1993;21:929-33.
21. Bendich A, Machlin IJ, Scandurra O, et al. The antioxidant role of vitamin C. Adv Free Radic Biol Med. 1986;2:419-444.
22. Taddei S, Virdis A, Ghiadoni L, et al. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation. 1998;97:2222-2229.
23. Panza JA, Casino PR, Badar DM, et al. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation. 1993;87:1475-1481.
24. Creager MA, Gallagher SJ, Girerd XJ, et al. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992;90:1248-1253.
25. Taddei S, Virdis A, Mattei P, et al. Hypertension causes premature aging of endothelial function in humans. Hypertension. 1997;29:736-743.
26. Taddei S, Virdis A, Mattei P, et al. Defective L-arginine-NO pathway in offspring of essential hypertensive patients. Circulation. 1996;94:1298-1303.
27. Taddei S, Virdis A, Ghiadoni L, et al. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension. 1997;29(pt 2):274-279.
28. Keaney JF, Shwaery GT, Xu A, et al. 17β-Estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation. 1994;89:2251-2259.
29. Jackson TS, Xu A, Vita JA, et al. Ascorbate prevents the interaction of superoxide and nitric oxide only at high physiological concentrations. Circ Res. 1998;83:916-922.
30. Weiner CP, Lizasoain I, Baylis SA, et al. Induction of calcium-dependent nitric oxide synthesis by sex hormones. Proc Natl Acad Sci U S A. 1994;91:5212-5216.
31. Rosselli M, Imthurn B, Keller PJ, et al. Circulating nitric oxide (nitrite/ nitrate) levels in postmenopausal women substituted with 17 β-estradiol and norethisterone acetate. Hypertension. 1995;25(pt 2):848-853.
32. Tagawa H, Shimokawa H, Tagawa T, et al. Short-term estrogen augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilation in postmenopausal women. J Cardiovasc Pharmacol. 1997;30:481-488.
33. Luscher TF, Barton M. Biology of the endothelium. Clin Cardiol. 1997; 20(suppl II):II-3-II-10.
34. Ghiadoni L, Taddei S, Virdis A, et al. Endothelial function and common carotid wall thickening in essential hypertensive patients. Hypertension. 1998;32:25-32.
35. Sorensen KE, Dorup I, Hermann AP, et al. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation. 1998; 97:1234-1238.
36. McCrohon JA, Adams MR, McCredie RJ, et al. Hormone replacement therapy is associated with improved arterial physiology in healthy postmenopausal women. Clin Endocrinol. 1996;45:435-441.
37. Gerhard M, Walsh BW, Tawakol A, et al. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation. 1998;98:1158-1163.
38. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 1998;280:605-613.
39. Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials. 1998; 19:61-109.